Research Briefing | Apr 26, 2021

India | Worsening health conditions crystalise downside risks

Ipad Frame (30)

The rapidly swelling second wave has taken a big toll on the country’s health infrastructure. The health system has collapsed in the worst hit states, with even the national capital, Delhi, facing acute shortage of oxygen and Covid-19 hospital beds. While the official mortality rate has edged lower, it masks a rapidly rising death count. Deaths are now doubling every ten days (as opposed to an average of 29 days in the first wave) and even this figure is likely buttressed by delayed or under-reporting of deaths.

What you will learn from this report:

  • India’s escalating health burden, faltering vaccination rate, and lack of a convincing government strategy to contain the pandemic have prompted us to downgrade our 2021 GDP growth forecast to 10.2% from 11.8% previously.
  • GDP is expected to contract sequentially in Q2 and average 1.47% q/q sa in 2021. This is a notable downgrade from our pre-second wave average growth forecast of 1.64%, but represents a modest uptick from 1.44% in 2020.
  •  Notwithstanding the likelihood of further mobility restrictions, we expect India’s targeted lockdown approach, less stringent restrictions, and resilient consumer and business behaviour to mitigate the economic impact of the second wave.
Back to Resource Hub

Related Services

US bill next to calculator which says recession

Post

US-China relations improve, yet industrial recession remains likely

For the first time this year, our global industrial production outlook for 2025 has been upgraded. However, we still anticipate an industrial recession in Q2 and Q3.

Find Out More
Industry is performing worse than the broader economy globally

Post

Positive tariff news does little to dispel overall uncertainty

We've nudged up our world GDP growth forecasts for 2025 and 2026 by 0.1ppt to 2.4%, in part to reflect the temporary but substantial reduction in tariffs between the US and China.

Find Out More